Literature DB >> 14989228

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.

Emilio Bombardieri1, Cumali Aktolun, Richard P Baum, Angelika Bishof-Delaloye, John Buscombe, Jean François Chatal, Lorenzo Maffioli, Roy Moncayo, Luc Mortelmans, Sven N Reske.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14989228     DOI： 10.1007/s00259-003-1358-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  41 in total

1.  Radiological Protection in Biomedical Research. A report of Committee 3 adopted by the International Commission on Radiological Protection.

Authors: 
Journal:  Ann ICRP       Date:  1991

2.  Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningioma.

Authors:  S Klutmann; K H Bohuslavizki; W Brenner; A Behnke; N Tietje; S Kröger; H H Hugo; H M Mehdorn; M Clausen; E Henze
Journal:  J Nucl Med       Date:  1998-11       Impact factor: 10.057

3.  Somatostatin-receptor imaging in the localization of endocrine tumors.

Authors:  S W Lamberts; W H Bakker; J C Reubi; E P Krenning
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

4.  Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53).

Authors: 
Journal:  Ann ICRP       Date:  1998

5.  Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.

Authors:  R Lebtahi; G Cadiot; N Delahaye; R Genin; D Daou; M C Peker; D Chosidow; M Faraggi; M Mignon; D Le Guludec
Journal:  J Nucl Med       Date:  1999-10       Impact factor: 10.057

Review 6.  Radiolabeled peptides in diagnosis and tumor imaging: clinical overview.

Authors:  Richard R P Warner; Thomas M O'dorisio
Journal:  Semin Nucl Med       Date:  2002-04       Impact factor: 4.446

7.  Somatostatin receptor imaging in patients with sarcoidosis.

Authors:  D J Kwekkeboom; E P Krenning; G S Kho; W A Breeman; P M Van Hagen
Journal:  Eur J Nucl Med       Date:  1998-09

8.  Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease.

Authors:  J M Zuetenhorst; C A Hoefnageli; H Boot; R A Valdés Olmos; B G Taal
Journal:  Nucl Med Commun       Date:  2002-08       Impact factor: 1.690

Review 9.  Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan).

Authors:  J O Olsen; R V Pozderac; G Hinkle; T Hill; T M O'Dorisio; W J Schirmer; E C Ellison; M S O'Dorisio
Journal:  Semin Nucl Med       Date:  1995-07       Impact factor: 4.446

10.  Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.

Authors:  E P Krenning; W H Bakker; P P Kooij; W A Breeman; H Y Oei; M de Jong; J C Reubi; T J Visser; C Bruns; D J Kwekkeboom
Journal:  J Nucl Med       Date:  1992-05       Impact factor: 10.057
View more
  7 in total

Review 1.  Review of functional/anatomical imaging in oncology.

Authors:  Stephanie N Histed; Maria L Lindenberg; Esther Mena; Baris Turkbey; Peter L Choyke; Karen A Kurdziel
Journal:  Nucl Med Commun       Date:  2012-04       Impact factor: 1.690

Review 2.  [PET-CT for neuroendocrine tumors and nuclear medicine therapy options].

Authors:  K Scheidhauer; M Miederer; F C Gaertner
Journal:  Radiologe       Date:  2009-03       Impact factor: 0.635

3.  Adsorption of metallic radionuclides on plastic phantom walls.

Authors:  Mi-Ae Park; Ashfaq Mahmood; Robert E Zimmerman; Naengnoi Limpa-Amara; G Mike Makrigiorgos; Stephen C Moore
Journal:  Med Phys       Date:  2008-04       Impact factor: 4.071

4.  EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.

Authors:  David Taïeb; Henri J Timmers; Elif Hindié; Benjamin A Guillet; Hartmut P Neumann; Martin K Walz; Giuseppe Opocher; Wouter W de Herder; Carsten C Boedeker; Ronald R de Krijger; Arturo Chiti; Adil Al-Nahhas; Karel Pacak; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-28       Impact factor: 9.236

5.  Quantitative analysis of phantom studies of 111In and 68Ga imaging of neuroendocrine tumours.

Authors:  L Jönsson; A Stenvall; E Mattsson; E Larsson; A Sundlöv; T Ohlsson; C Hindorf
Journal:  EJNMMI Phys       Date:  2018-02-20

Review 6.  Role of Combined 68Ga DOTA-Peptides and 18F FDG PET/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms.

Authors:  Chalermrat Kaewput; Sobhan Vinjamuri
Journal:  Diagnostics (Basel)       Date:  2022-01-22

7.  Chronic bronchitis mimicking metastases from thyroid medullary carcinoma demonstrated by indium-111 pentetreotide scintigraphy.

Authors:  Savas Karyagar; Mehmet Mulazimoglu; Sevda S Karyagar; Metin Halac; Tevfik Ozpacaci
Journal:  Cancer Imaging       Date:  2008-04-24       Impact factor: 3.909
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.